In a biological crossover that sounds more like science fiction than laboratory reality, researchers have successfully enabled mammalian cells to harvest energy from light. By transplanting photosynthetic machinery from common spinach into the eyes of mice, a team of scientists has demonstrated that animal cells can be “upgraded” to produce their own chemical energy, a breakthrough that could eventually lead to new ways of treating inflammation and cellular decay.
The study, published in the journal Cell, details how researchers bypassed the evolutionary divide between plants and animals. While animals typically rely on the consumption of organic matter for energy, the team utilized nanoparticles to deliver the light-harvesting components of plants directly into animal cells. This process allows the cells to convert light into molecules that carry energy, effectively mimicking the primary function of a leaf.
For the researchers involved, the project began not with complex synthetic biology, but with a trip to the grocery store. Kuoran Xing, a bionanotechnologist at the National University of Singapore, sought a way to replicate a phenomenon seen in nature: kleptoplasty. Certain sea slugs are known to “steal” chloroplasts from the algae they eat, incorporating them into their own tissues to survive on sunlight for weeks at a time.
To see if this was possible in mammals, Xing purchased several varieties of leafy greens from FairPrice, a local supermarket. After testing red spinach, water spinach, and lettuce, the team found that standard spinach (Spinacia oleraceae) provided the most efficient photosynthetic machinery for their needs.
Engineering the ‘LEAF’ Nanoparticle
The core of the discovery lies in the isolation of chloroplasts—the green organelles where photosynthesis occurs. However, simply injecting chloroplasts into a cell is not enough. To make the machinery functional within a mammalian environment, the researchers focused on the thylakoid grana, the pancake-like stacks of membranes that capture light energy.
The team encapsulated these grana into specialized nanoparticles, which they named LEAFs. These particles act as a delivery vehicle, allowing mammalian cells to internalize the plant machinery without triggering an immediate immune rejection or cellular collapse.
Once inside the cell, the LEAFs perform a specific, limited version of photosynthesis. In a natural plant, photosynthesis happens in two stages: the light-dependent reactions create energy-carrying molecules, and the light-independent reactions (the Calvin cycle) use that energy to build carbohydrates like sugar. The LEAFs only support the first stage.
By exposing the treated cells to light, the researchers observed the production of ATP (adenosine triphosphate) and NADPH (nicotinamide adenine dinucleotide phosphate). These are the primary “energy currencies” of the cell, essential for everything from DNA repair to the movement of molecules across membranes.
| Feature | Natural Plant Photosynthesis | LEAFs-Induced Photosynthesis |
|---|---|---|
| Energy Source | Sunlight | Light (via nanoparticles) |
| Primary Output | ATP, NADPH, and Carbohydrates | ATP and NADPH only |
| Host Organism | Plants / Algae | Mammalian Cells (Mice) |
| Sustainability | Permanent/Biological | Temporary/Nanoparticle-based |
Therapeutic Potential in the Eye
While the ability to make a mouse cell “photosynthesize” may seem like a curiosity, the implications for medicine are significant. The researchers focused on the eyes of mice because the eye is naturally designed to let light pass through to the retina, making it an ideal site for light-driven therapy.
By boosting the energy levels of cells in the eye through light, the researchers found they could help tame inflammation. When cells are stressed or damaged, they often run out of the ATP required to maintain homeostasis and fight off inflammatory responses. By providing an external, light-driven energy source, the LEAFs can potentially “recharge” these cells, allowing them to recover more effectively.
David Tai Leong, a biologist at the National University of Singapore and co-author of the study, describes the process as a form of biological appropriation. “We are stealing the entire technology that has evolved over millions of years in plants and are able to transplant it into the animal system,” Leong said.
However, other experts urge a measured perspective on the current state of the research. Corey Allard, a cell biologist at Harvard University, noted that the discovery is promising but still in its infancy. “Any effort to do this is necessarily going to look like a party trick at first,” Allard said.
Allard emphasized that the real work begins now, as researchers must determine the limitations of the technique. Key questions remain regarding how long the LEAFs remain active inside a cell, which specific cell types are most receptive to the transplant, and whether the process can be scaled for human use without adverse side effects.
The Path Toward Bio-Hybrid Medicine
The success of the LEAFs project opens the door to a broader field of “cross-kingdom” transplants. If researchers can successfully integrate plant organelles into animal cells, it could lead to a new class of therapeutics where light is used as a non-invasive drug to power healing in damaged tissues.
Beyond the eye, potential applications could include treating ischemic tissues—areas of the body where blood flow is restricted and oxygen (and thus energy) is low. If these areas can be reached by nanoparticles and exposed to specific wavelengths of light, it might be possible to sustain cells that would otherwise die from energy starvation.
For now, the researchers are focused on refining the stability of the LEAFs and exploring which other plant species might offer even more robust photosynthetic machinery. The transition from a “party trick” to a clinical treatment will require rigorous testing to ensure that the introduction of plant-based nanoparticles does not interfere with the complex signaling pathways of mammalian biology.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. The research described is currently in the experimental stage and has not been approved for human clinical use.
The next phase of research will likely focus on the longevity of the photosynthetic effect in vivo and the exploration of targeted delivery systems to other organs. Updates on these trials are expected to be published in upcoming peer-reviewed journals as the National University of Singapore team expands their scope.
Do you think light-driven cellular energy is the future of medicine? Share your thoughts in the comments or join the conversation on our social channels.
